Sage Journals: Discover world-class research

Abstract

Background

Magnetic resonance imaging (MRI) has high sensitivity but low specificity for breast cancer, and consequently, new techniques to improve the specificity of breast MRI in diagnosing breast cancer are under development.

Purpose

To assess the ability of the apparent diffusion coefficient (ADC) compared with the ADC ratio (ADCr) to differentially diagnose benign compared with malignant breast lesions.

Material and Methods

Forty-eight women with breast lesions (average age, 45 years) underwent MRI scanning including T1-weighted dynamic contrast-enhanced (DCE) scanning and diffusion-weighted imaging (DWI). The average ADC and ADCr values for both lesions and pectoralis major muscles (ADC_rmuscle and ADCr_muscle) were measured in patients with malignant (n = 25) and benign (n = 23) breast lesions. The ADCr of the contralateral breast (ADCr _{contralateral}) was also evaluated. All histology was confirmed by pathological analysis of biopsied tissue. ADC and ADCr values were analyzed using receiver-operating characteristic (ROC) curves.

Results

For benign lesions compared with malignant lesions, lesion-side ADC was 1.45 vs. 1.05, respectively (P < 0.001), normal-side ADC was 1.82 vs.1.64 (P = 0.002), ADC_rmuscle was 1.35 vs. 0.9 (P < 0.001), and ADCr_{contralateral} was 0.79 vs. 0.64 (P = 0.001). ADCr_muscle showed higher sensitivity (82.61%) and specificity (96.00%) than ADCr_{contralateral} (60.87% and 92.00%, respectively) and ADC (69.57% and 96.00%) for discriminating malignant from benign lesions. The AUC using ADCr_muscle had higher discriminatory power (0.92, P < 0.001) for malignant versus benign breast lesions compared with either ADC (0.82, P < 0.001) or ADCr_{contralateral} (0.78, P = 0.001).

Conclusion

The ADCr_muscle value showed higher sensitivity and specificity and improved diagnostic accuracy compared with either ADC or ADCr_{contralateral} in differentiating benign from malignant breast lesions.

Keywords

ADC ratio breast lesions breast magnetic resonance imaging (MRI)breast cancer

Get full access to this article

View all access options for this article.

References

DeMartini

Lehman

. A review of current evidence-based clinical applications for breast magnetic resonance imaging. Top Magn Reson Imaging 2008; 19: 143–150.

Sharma

Sah

Parshad

. Role of apparent diffusion coefficient values for the differentiation of viable and necrotic areas of breast cancer and its potential utility to guide voxel positioning for MRS in the absence of dynamic contrast-enhanced MRI data. Magn Reson Imaging 2012; 30: 649–655.

Thomassin-Naggara

De Bazelaire

Chopier

. Diffusion-weighted MR imaging of the breast: advantages and pitfalls. Eur J Radiol 2013; 82: 435–443.

Brandão

Lehman

Partridge

. Breast magnetic resonance imaging: diffusion- weighted imaging. Magn Reson Imaging Clin N Am 2013; 21: 321–336.

Pickles

Gibbs

Lowry

. Diffusion changes precede size reduction in neoadjuvant treatment of breast cancer. Magn Reson Imaging 2006; 24: 843–847.

Motoshima

Irie

Nakazono

. Diffusion-weighted MR imaging in gynecologic cancers. J Gynecol Oncol 2011; 22: 275–287.

Guo

Cai

. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002; 16: 172–178.

Woodhams

Matsunaga

Iwabuchi

. Diffusion-weighted imaging of malignant breast tumors: the usefulness of apparent diffusion coefficient (ADC) value and ADC map for the detection of malignant breast tumors and evaluation of cancer extension. J Comput Assist Tomogr 2005; 29: 644–649.

Woodhams

Kakita

Hata

. Identification of residual breast carcinoma following neoadjuvant chemotherapy: diffusion-weighted imaging – comparison with contrast-enhanced MR imaging and pathologic findings. J Comput Assist Tomogr 2005; 29: 644–649.

10.

Koh

Pehani

. Diffusion-weighted MR: a new functional clinical technique for tumor imaging. Br J Radiol 2007; 79: 633–635.

11.

Hirano

Satake

Ishigaki

. Diffusion-weighted imaging of breast masses: comparison of diagnostic performance using various apparent diffusion coefficient parameters. Am J Roentgenol 2012; 198: 717–722.

12.

Gimi

Cederberg

Derinkuyu

. Utility of apparent diffusion coefficient ratios in distinguishing common pediatric cerebellar tumors. Acad Radiol 2012; 19: 794–800.

13.

Cao

Zhou

X-J

Zao

J-L

. Selection of b value in diagnosis of breast cancers with 3.0T DWI. China Medical Devices 2013; 8: 150–160.

14.

American College of Radiology. Breast imaging reporting and data system (BI-RADS atlas) , Reston, VA: American College of Radiology, 2003.

15.

Lanza

Bhagra

Nair

. Measurement of human skeletal muscle oxidative capacity by 31 P-MR spectroscopy: a cross-validation with in vitro measurements. J Magn Reson Imaging 2011; 34: 1143–1150.

16.

Busard

Mijatovic

van Kuijk

. Magnetic resonance imaging in the evaluation of (deep infiltrating) endometriosis: the value of diffusion-weighted imaging. J Magn Reson Imaging 2010; 31: 1117–1123.

17.

Kuroki

Nasu

Kuroki

. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004; 3: 79–85.

18.

Inoue

Kozawa

Mizukoshi

. Usefulness of diffusion-weighted imaging of breast tumors: quantitative and visual assessment. Jpn J Radiol 2011; 29: 429–436.

19.

Sonmez

Cuce

Mutlu

. Value of diffusion-weighted MRI in the differentiation of benign and malign breast lesions. Wien Klin Wochenschr 2011; 123: 655–661.

20.

Chen

Jin

. Conspicuity of breast lesions at different b values on diffusion-weighted imaging. BMC Cancer 2012; 12: 334–334.

21.

Chan

. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr 2009; 33: 63–69.

22.

Belli

Costantini

Bufi

. Diffusion-weighted imaging in breast lesion evaluation. Radiol Med 2010; 115: 51–69.

23.

Bulakbasi

Guvenc

Onguru

. The added value of the apparent diffusion coefficient calculation to magnetic resonance imaging in the differentiation and grading of malignant brain tumors. J Comput Assist Tomogr 2004; 28: 735–746.

24.

Xing

Sheng

Chen

. Relative apparent diffusion coefficient: a promising tool to differentiate metastatic from benign lymph nodes in animal models. Chin Med J (Engl) 2011; 124: 2907–2910.

25.

Park

Kim

. Relative apparent diffusion coefficient: determination of reference site and validation of benefit for detecting metastatic lymph nodes in uterine cervical cancer. J Magn Reson Imaging 2009; 29: 383–390.

26.

Rahbar

Partridge

Eby

. Characterization of ductal carcinoma in situ on diffusion weighted breast MRI. Eur Radiol 2011; 21: 2011–2019.

27.

Xie

Yin

. Diagnostic value of ADC and rADC of diffusion weighted imaging in malignant breast lesions. Zhonghua Zhong Liu Za Zhi 2010; 32: 217–220.

28.

Zhang

Cheng

. The diagnostic value of apparent diffusion coefficient in breast lesions. Chinese Journal of Medical Imaging 2010; 18: 485–491.

29.

Kul

Cansu

Alhan

. Contribution of diffusion-weighted imaging to dynamic contrast-enhanced MRI in the characterization of breast tumors. Am J Roentgenol 2011; 196: 210–217.

30.

Şahin

Arıbal

. The role of apparent diffusion coefficient values in the differential diagnosis of breast lesions in diffusion-weighted MRI. Diagn Interv Radiol 2013; 19: 457–462.

Significance of the ADC ratio in the differential diagnosis of breast lesions